These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 20172966

  • 1. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M.
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
    Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M.
    Circulation; 2008 May 06; 117(18):2340-50. PubMed ID: 18427132
    [Abstract] [Full Text] [Related]

  • 3. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr 06; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug 06; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 5. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH.
    Arterioscler Thromb Vasc Biol; 2010 Jul 06; 30(7):1407-14. PubMed ID: 20448207
    [Abstract] [Full Text] [Related]

  • 6. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B.
    J Biol Chem; 1993 Sep 15; 268(26):19650-5. PubMed ID: 8396143
    [Abstract] [Full Text] [Related]

  • 7. Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.
    Iwasa M, Kobayashi H, Yasuda S, Kawamura I, Sumi S, Yamada Y, Shiraki T, Yamaki T, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.
    J Cardiovasc Pharmacol; 2010 Jun 15; 55(6):625-34. PubMed ID: 20351564
    [Abstract] [Full Text] [Related]

  • 8. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
    Yang H, Li H, Wang Z, Shi Y, Jiang G, Zeng F.
    J Surg Res; 2013 Dec 15; 185(2):825-32. PubMed ID: 23890403
    [Abstract] [Full Text] [Related]

  • 9. Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.
    Angelone T, Filice E, Quintieri AM, Imbrogno S, Amodio N, Pasqua T, Pellegrino D, Mulè F, Cerra MC.
    Nutr Metab Cardiovasc Dis; 2012 Jun 15; 22(6):486-94. PubMed ID: 21186112
    [Abstract] [Full Text] [Related]

  • 10. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W, Holt LJ, Prince RD, Jones GX, Aravindhan K, Szapacs M, Barbour AM, Jolivette LJ, Lepore JJ, Willette RN, DeAngelis E, Jucker BM.
    Cardiovasc Diabetol; 2013 Oct 14; 12():148. PubMed ID: 24125539
    [Abstract] [Full Text] [Related]

  • 11. Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
    Green BD, Mooney MH, Gault VA, Irwin N, Bailey CJ, Harriott P, Greer B, Flatt PR, O'Harte FP.
    Metabolism; 2004 Feb 14; 53(2):252-9. PubMed ID: 14767880
    [Abstract] [Full Text] [Related]

  • 12. Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
    Salling HK, Döhler KD, Engstrøm T, Treiman M.
    Regul Pept; 2012 Oct 10; 178(1-3):51-5. PubMed ID: 22749991
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
    Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA.
    Hepatology; 2010 May 10; 51(5):1584-92. PubMed ID: 20225248
    [Abstract] [Full Text] [Related]

  • 14. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
    Kappe C, Zhang Q, Holst JJ, Nyström T, Sjöholm A.
    Am J Physiol Cell Physiol; 2013 Nov 15; 305(10):C1041-9. PubMed ID: 23986202
    [Abstract] [Full Text] [Related]

  • 15. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
    Li N, Lu J, Willars GB.
    PLoS One; 2012 Nov 15; 7(10):e47936. PubMed ID: 23094100
    [Abstract] [Full Text] [Related]

  • 16. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
    Fehmann HC, Jiang J, Schweinfurth J, Wheeler MB, Boyd AE, Göke B.
    Peptides; 1994 Nov 15; 15(3):453-6. PubMed ID: 7937318
    [Abstract] [Full Text] [Related]

  • 17. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y.
    Hypertension; 2012 Sep 15; 60(3):833-41. PubMed ID: 22868389
    [Abstract] [Full Text] [Related]

  • 18. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor.
    Kedees MH, Guz Y, Grigoryan M, Teitelman G.
    Peptides; 2013 Oct 15; 48():36-44. PubMed ID: 23927844
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
    Koehler JA, Kain T, Drucker DJ.
    Endocrinology; 2011 Sep 15; 152(9):3362-72. PubMed ID: 21771884
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.